» Articles » PMID: 36452858

The Nose That Broke the Hip! Tumor Induced Osteomalacia Secondary to Phosphaturic Mesenchymal Nasal Tumor : A Case Report

Overview
Publisher Springer
Date 2022 Dec 1
PMID 36452858
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor induced osteomalacia is a rare paraneoplastic syndrome caused by usually small mesenchymal tumors. The tumors are commonly located in the extremities whereas occurrence in the nasal cavity is quite rare. An 18 year old male presented with asymmetric weakness of both lower limbs and difficulty in walking since one year. On evaluation he was found to have open femur head physes and iliac apophyses, low serum Phosphorus, low vitamin D, normal serum calcium, elevated PTH & alkaline phosphatase levels. FGF-23 levels in serum were elevated. DOTA NOC PET CT revealed tumor in the left nasal cavity abutting the nasal septum. Surgical excision of the tumor resulted in normalisation of the serum levels of phosphorus, vitamin D and FGF-23. This case report indicates the importance of maintaining high clinical suspicion and early detection of causative tumor using appropriate imaging techniques.

Citing Articles

Advanced tumour-induced osteomalacia secondary to sinonasal phosphaturic mesenchymal tumour.

van Wijk M, van Rensburg L, Berndorfler B, Opperman J, Grobbelaar J, Afrogheh A SA J Radiol. 2024; 28(1):2975.

PMID: 39506984 PMC: 11538104. DOI: 10.4102/sajr.v28i1.2975.

References
1.
Agrawal K, Bhadada S, Mittal B, Shukla J, Sood A, Bhattacharya A . Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2014; 40(1):e6-e10. DOI: 10.1097/RLU.0000000000000460. View

2.
Lee J, Su S, Changou C, Yang R, Tsai K, Collins M . Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol. 2016; 29(11):1335-1346. DOI: 10.1038/modpathol.2016.137. View

3.
Imanishi Y, Hashimoto J, Ando W, Kobayashi K, Ueda T, Nagata Y . Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab. 2011; 30(1):93-9. DOI: 10.1007/s00774-011-0290-8. View

4.
Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T . Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113(4):561-8. PMC: 338262. DOI: 10.1172/JCI19081. View

5.
Clifton-Bligh R, Hofman M, Duncan E, Sim I, Darnell D, Clarkson A . Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT. J Clin Endocrinol Metab. 2013; 98(2):687-94. DOI: 10.1210/jc.2012-3642. View